$9.98
0.50% yesterday
Nasdaq, Oct 15, 10:00 pm CET
ISIN
US92556V1061
Symbol
VTRS

Viatris Stock price

$9.98
+0.38 3.96% 1M
+2.50 33.42% 6M
-2.47 19.84% YTD
-1.86 15.71% 1Y
+0.37 3.85% 3Y
-5.76 36.57% 5Y
-32.75 76.64% 10Y
-9.96 49.95% 20Y
Nasdaq, Closing price Wed, Oct 15 2025
+0.05 0.50%

Key metrics

Basic
Market capitalization
$11.6b
Enterprise Value
$23.8b
Net debt
$12.1b
Cash
$666.2m
Shares outstanding
1.2b
Valuation (TTM | estimate)
P/E
negative | 4.3
P/S
0.8 | 0.8
EV/Sales
1.7 | 1.7
EV/FCF
13.9
P/B
0.8
Dividends
DPS
$0.48
Yield 1Y | 5Y
4.8% | 2.7%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
-90.6% | 117.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$14.1b | $14.2b
EBITDA
$4.2b | $4.2b
EBIT
$1.4b | $3.8b
Net Income
$-3.5b | $2.7b
Free Cash Flow
$1.7b
Growth (TTM | estimate)
Revenue
-7.4% | -3.8%
EBITDA
-0.4% | -10.9%
EBIT
1.9% | 113.7%
Net Income
-436.5% | 527.8%
Free Cash Flow
-9.4%
Margin (TTM | estimate)
Gross
40.2%
EBITDA
29.7% | 29.4%
EBIT
10.1%
Net
-24.6% | 19.1%
Free Cash Flow
12.1%
Financial Health
Equity Ratio
44.9%
Return on Equity
-3.4%
ROCE
4.6%
ROIC
4.0%
Debt/Equity
0.8
More
EPS
$-3.0
FCF per Share
$1.5
Short interest
3.0%
Employees
32k
Rev per Employee
$460.0k
Show more

Is Viatris a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Viatris Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Viatris forecast:

2x Buy
14%
7x Hold
50%
5x Sell
36%

Analyst Opinions

14 Analysts have issued a Viatris forecast:

Buy
14%
Hold
50%
Sell
36%

Financial data from Viatris

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
14,116 14,116
7% 7%
100%
- Direct Costs 8,448 8,448
3% 3%
60%
5,668 5,668
13% 13%
40%
- Selling and Administrative Expenses 3,399 3,399
21% 21%
24%
- Research and Development Expense 838 838
3% 3%
6%
4,189 4,189
0% 0%
30%
- Depreciation and Amortization 2,759 2,759
2% 2%
20%
EBIT (Operating Income) EBIT 1,430 1,430
2% 2%
10%
Net Profit -3,468 -3,468
436% 436%
-25%

In millions USD.

Don't miss a Thing! We will send you all news about Viatris directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Viatris Stock News

Neutral
PRNewsWire
about 12 hours ago
Strengthens Viatris' Presence in Japan With the Addition of Two Innovative Assets Targeting Areas of Significant Unmet Medical Need Leverages Existing Infrastructure and Expertise in Central Nervous System Therapy Area Aligned with Strategy to Target Accretive Regional Business Development Opportunities PITTSBURGH , Oct. 15, 2025 /PRNewswire/ -- Viatris Inc . (Nasdaq: VTRS), a global healthcare...
Neutral
PRNewsWire
3 days ago
PITTSBURGH , Oct. 13, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will participate in two upcoming healthcare conferences in November 2025. The Company will participate in a fireside chat at the UBS Global Healthcare Conference 2025 on November 11, 2025, at 8:45 a.m.
Positive
Seeking Alpha
4 days ago
Fourteen of the highest-yielding, 'safer' S&P 500 dividend stocks are currently attractively priced, with free cash flow supporting their payouts. Top ten S&P 500 dividend 'dogs' are projected to deliver 23.93% to 38.57% net gains by October 2026, based on analyst targets. Stocks like CAG, VZ, DOC, BMY, KVUE, CPB, UDR, VTRS, KIM, TFC, KEY, HPQ, T, and RF meet the ideal of dividends from $1K inv...
More Viatris News

Company Profile

Viatris, Inc. engages in the commercialization and manufacturing of pharmaceutical products. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Head office United States
CEO Scott Smith
Employees 32,000
Founded 2019
Website www.viatris.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today